The Physicochemical Properties of Graphene Nanocomposites Influence the Anticancer Effect
- PMID: 31354821
- PMCID: PMC6636583
- DOI: 10.1155/2019/7254534
The Physicochemical Properties of Graphene Nanocomposites Influence the Anticancer Effect
Abstract
Graphene nanocomposite is an inorganic nanocomposite material, which has been widely used in the treatment of tumor at present due to its ability of drug loading, modifiability, photothermal effect, and photodynamic effect. However, the application of graphene nanocomposite is now limited due to the fact that the functions mentioned above are not well realized. This is mainly because people do not have a systematic understanding of the physical and chemical properties of GO nanomolecules, so that we cannot make full use of GO nanomolecules to make the most suitable materials for the use of medicine. Here, we are the first to discuss the influence of the physicochemical properties of graphene nanocomposite on the various functions related to their antitumor effects. The relationship between some important physicochemical properties of graphene nanocomposite such as diameter, shape, and surface chemistry and their functions related to antitumor effects was obtained through analysis, which provides evidence for the application of related materials in the future.
Figures
Similar articles
-
Pluronic-based graphene oxide-methylene blue nanocomposite for photodynamic/photothermal combined therapy of cancer cells.Photodiagnosis Photodyn Ther. 2020 Mar;29:101640. doi: 10.1016/j.pdpdt.2019.101640. Epub 2019 Dec 30. Photodiagnosis Photodyn Ther. 2020. PMID: 31899381
-
Hierarchical nanocomposites of graphene oxide and PEGylated protoporphyrin as carriers to load doxorubicin hydrochloride for trimodal synergistic therapy.J Mater Chem B. 2018 Jul 28;6(28):4687-4696. doi: 10.1039/c8tb00733k. Epub 2018 Jul 4. J Mater Chem B. 2018. PMID: 32254413
-
Enhanced synergetic antibacterial activity by a reduce graphene oxide/Ag nanocomposite through the photothermal effect.Colloids Surf B Biointerfaces. 2020 Jan 1;185:110616. doi: 10.1016/j.colsurfb.2019.110616. Epub 2019 Nov 5. Colloids Surf B Biointerfaces. 2020. PMID: 31740323
-
Chasing Graphene-Based Anticancer Drugs: Where are We Now on the Biomedical Graphene Roadmap?Int J Nanomedicine. 2024 May 2;19:3973-3989. doi: 10.2147/IJN.S447397. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38711615 Free PMC article. Review.
-
Recent Progress in Graphene/Polymer Nanocomposites.Adv Mater. 2021 Feb;33(6):e2001105. doi: 10.1002/adma.202001105. Epub 2020 Sep 6. Adv Mater. 2021. PMID: 32893409 Review.
Cited by
-
Properties and Applications of Graphene and Its Derivatives in Biosensors for Cancer Detection: A Comprehensive Review.Biosensors (Basel). 2022 Apr 24;12(5):269. doi: 10.3390/bios12050269. Biosensors (Basel). 2022. PMID: 35624570 Free PMC article. Review.
-
Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment.Cancers (Basel). 2021 Jul 15;13(14):3539. doi: 10.3390/cancers13143539. Cancers (Basel). 2021. PMID: 34298753 Free PMC article. Review.
-
GO Nanosheets: Promising Nano Carrier for the S29, 1-(2-Chloro-2-(4-chlorophenyl-ethyl)-N-(4-fluorobenzyl)-1H-pyrazolo[3,4-d] pyrimidin-4-amine, Therapeutic Agent in Neuroblastoma.Int J Mol Sci. 2020 Sep 3;21(17):6430. doi: 10.3390/ijms21176430. Int J Mol Sci. 2020. PMID: 32899395 Free PMC article.
-
Bi2O3-Doped WO3 Nanoparticles Decorated on rGO Sheets: Simple Synthesis, Characterization, Photocatalytic Performance, and Selective Cytotoxicity toward Human Cancer Cells.ACS Omega. 2023 Jul 3;8(28):25020-25033. doi: 10.1021/acsomega.3c01644. eCollection 2023 Jul 18. ACS Omega. 2023. PMID: 37483253 Free PMC article.
-
Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds.Front Pharmacol. 2021 Aug 17;12:702611. doi: 10.3389/fphar.2021.702611. eCollection 2021. Front Pharmacol. 2021. PMID: 34483905 Free PMC article. Review.
References
-
- Duggan S. T., Keating G. M., Ferrandina G., Kesterson J. P., Lorusso D., Muggia F. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposis sarcoma. Drugs. 2011;71(18):2531–2558. doi: 10.2165/11207510-000000000-00000. - DOI - PubMed
-
- Feng X., Long Y. Y., Liao H., Sun Y., Han W. Q., Zhen Y. H. J. C. C. J. C. Application of nanotechnology in cancer therapy and imaging. CA: A Cancer Journal for Clinicians. 2010;58:97–110. - PubMed
Publication types
LinkOut - more resources
Full Text Sources